FDAsafety guidance66% confidence
FDA AP — MORPHINE SULFATE (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Mankind Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA200812. Sponsor: STRIDES PHARMA INTL. Submission status: AP. Submission type: SUPPL. Active ingredients: MORPHINE SULFATE.
Supporting Context
- Therapeutic area
- Cardiovascular · Anticholinergic
- Sub-indication
- General
Related signal: FDA grants AP status for Atropine Sulfate ANDA218148 by Mankind Pharma